Related references
Note: Only part of the references are listed.Determination of MIC Distribution and Epidemiological Cutoff Values for Bedaquiline and Delamanid in Mycobacterium tuberculosis Using the MGIT 960 System Equipped with TB eXiST
Peter M. Keller et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2015)
Evolutionary history and global spread of the Mycobacterium tuberculosis Beijing lineage
Matthias Merker et al.
NATURE GENETICS (2015)
Delamanid: A Review of Its Use in Patients with Multidrug-Resistant Tuberculosis
Hannah A. Blair et al.
DRUGS (2015)
A mutation associated with clofazimine and bedaquiline cross-resistance in MDR-TB following bedaquiline treatment
Akos Somoskovi et al.
EUROPEAN RESPIRATORY JOURNAL (2015)
Cross-Resistance between Clofazimine and Bedaquiline through Upregulation of MmpL5 in Mycobacterium tuberculosis
Ruben C. Hartkoorn et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2014)
Mechanism of Action of 5-Nitrothiophenes against Mycobacterium tuberculosis
Ruben C. Hartkoorn et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2014)
Multidrug-Resistant Tuberculosis and Culture Conversion with Bedaquiline
Andreas H. Diacon et al.
NEW ENGLAND JOURNAL OF MEDICINE (2014)
Delamanid for Multidrug-Resistant Pulmonary Tuberculosis
Maria Tarcela Gler et al.
NEW ENGLAND JOURNAL OF MEDICINE (2012)
Impact of fgd1 and ddn Diversity in Mycobacterium tuberculosis Complex on In Vitro Susceptibility to PA-824
Silke Feuerriegel et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2011)
Multicentre laboratory validation of the colorimetric redox indicator (CRI) assay for the rapid detection of extensively drug-resistant (XDR) Mycobacterium tuberculosis
Anandi Martin et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2011)
Metabolic Engineering of Cofactor F420 Production in Mycobacterium smegmatis
Ghader Bashiri et al.
PLOS ONE (2010)
Molecular insights into the biosynthesis of the F420 coenzyme
Farhad Forouhar et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2008)
OPC-67683, a nitro-dihydro-imidazooxazole derivative with promising action against tuberculosis in vitro and in mice
Makoto Matsumoto et al.
PLOS MEDICINE (2006)
Demonstration that fbiC is required by Mycobacterium bovis BCG for coenzyme F420 and FO biosynthesis
KP Choi et al.
JOURNAL OF BACTERIOLOGY (2002)
Share Paper
